CAR T-cell therapy in DLBCL – opportunities and challenges

Kite-Gilead supported Industry Symposium (Hall B)

Thursday, October 24

15:30–17:00

15:30–15:55
Real world experience at the University of Chicago: the first certified CAR T center in the United States
Michael R. Bishop, University of Chicago, USA
16:00–16:25
CAR T-cell therapy at UKE: therapeutic approach interdisciplinary team, and logistics 
Francis Ayuketang Ayuk, University Hamburg Eppendorf, Germany
16:30–17:00
What is the role of CAR T-cells in the treatment of DLBCL?
Bertram Glaß, Helios Klinikum Berlin-Buch, Germany

© The International Congress on Controversies in Stem Cell and Cellular Therapies (COSTEM).

Contact:
Tel: +44 20 3289 9552